James Hoyes has been appointed president of EMD Serono, a U.S. affiliate of Merck KGaA. Mr. Hoyes will be responsible for driving the strategic direction of the U.S. commercial organization as well as managing the day-to-day business. Mr. Hoyes will also serve as a member of the executive management board for Merck Serono, the global pharmaceuticals division of Merck KGaA. “Jim’s experience, leadership and vision will add significant value to our US operations,” said Dr. Stefan Oschmann, presid...